
Keywords: CanL; canine leishmaniosis; MGA; N-methylglucamine antimoniate; APP; acute phase proteins; AHCC; active hexose correlated compound; ELISA; enzyme-linked immunosorbent assay; CBC; complete blood count; CRP; C-reactive protein; UPC; urinary protein/creatini